Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextran-40 for AKI in Decompensated Cirrhosis
NCT03070353Phase 3Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jul 2015
- Primary completion
- Jun 2016
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of dextran in acute kidney injury (AKI), sponsored by Ramathibodi Hospital. Started Jul 2015; status: completed.
02
Drugs
dextran
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT03070353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03070353.